E6G (p.Glu6Gly) variant of NFKBIA (NF-kappa-B inhibitor alpha)

E6G (p.Glu6Gly) in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.26 / 1. The record also includes population frequency data and structural context.

E6G (p.Glu6Gly) variant details